Shaanxi Micot Pharmaceutical Technology Co., Ltd. (HKG:2335)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
25.06
-0.98 (-3.76%)
Sep 10, 2026, 1:14 PM HKT

HKG:2335 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Selling, General & Admin
47.7823.4918.81
Research & Development
217.38130.09107.02
Operating Expenses
265.24153.58125.83
Operating Income
-265.24-153.58-125.83
Interest Expense
-132.71-67-37.65
Interest & Investment Income
2.012.013.24
Currency Exchange Gain (Loss)
1.930.480.23
Other Non Operating Income (Expenses)
-16.57-9.9-
EBT Excluding Unusual Items
-410.57-228-160.02
Gain (Loss) on Sale of Investments
1.660.872.03
Other Unusual Items
42.2242.221.18
Pretax Income
-366.69-184.91-156.81
Income Tax Expense
--0.02
Earnings From Continuing Operations
-366.69-184.91-156.83
Minority Interest in Earnings
2.262.412.2
Net Income
-364.44-182.51-154.63
Net Income to Common
-364.44-182.51-154.63
Net Income Growth
---
Shares Outstanding (Basic)
257243234
Shares Outstanding (Diluted)
257243234
Shares Change
-3.71%-
EPS (Basic)
-1.42-0.75-0.66
EPS (Diluted)
-1.42-0.75-0.66
EPS Growth
---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
23.05-138.01-109.04
Free Cash Flow Per Share
0.09-0.57-0.47
EBITDA
-261.98-150.12-120.98
D&A For EBITDA
3.253.464.85
EBIT
-265.24-153.58-125.83